A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF

This is a prospective, open-label, cluster-randomized controlled trial of 400 participants (aged 60 years or older, with additional stroke risk factors and \'actionable\' undertreated AF) from a total of 40 retail and outpatient community pharmacies. Participants will be randomized (by pharmacy) to either to an intervention arm of pharmacist-led OAC management versus an enhanced usual care arm, wherein physicians receive notification of \'actionable\' AF and patients are advised to schedule a physician clinic visit. The primary objective will be to determine the difference in proportion of patients with \'actionable AF\' receiving guideline concordant OAC therapy at 3 months in those randomized to intervention arm versus control arm.